TipRanks
Advertisement
Advertisement

IL:TEVA Stock Latest News

Teva announces published review on dopamine pathways in Tourette syndrome
The FlyTeva announces published review on dopamine pathways in Tourette syndrome
4d ago
TEVA
Teva announces new data for ecopipam
PremiumThe Fly
Teva announces new data for ecopipam
4d ago
TEVA
Exxon Mobil downgraded, BP upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Exxon Mobil downgraded, BP upgraded: Wall Street’s top analyst calls
4d ago
BP
ED
Teva, Samsung Bioepis expand strategic partnership to advance biosimilars
PremiumThe Fly
Teva, Samsung Bioepis expand strategic partnership to advance biosimilars
5d ago
TEVA
Teva initiated with a Buy at TD Cowen
PremiumThe Fly
Teva initiated with a Buy at TD Cowen
5d ago
TEVA
Teva announces FDA approval of Degevma as a biosimilar to Xgeva
PremiumThe FlyTeva announces FDA approval of Degevma as a biosimilar to Xgeva
7d ago
TEVA
Teva Rated Buy on Improving Balance Sheet, Emerging Pipeline, and Modest Upside to Current Share Price
Premium
Ratings
Teva Rated Buy on Improving Balance Sheet, Emerging Pipeline, and Modest Upside to Current Share Price
12d ago
TEVA
Microsoft upgraded, HubSpot initiated: Wall Street’s top analyst calls
Premium
The Fly
Microsoft upgraded, HubSpot initiated: Wall Street’s top analyst calls
12d ago
ALV
ARX
Teva initiated with an Outperform at Oppenheimer
PremiumThe Fly
Teva initiated with an Outperform at Oppenheimer
13d ago
TEVA
Teva presents new new real-world data on uzedy at Psych Congress
PremiumThe Fly
Teva presents new new real-world data on uzedy at Psych Congress
17d ago
TEVA
Teva announces new olanzapine post-hoc data
PremiumThe Fly
Teva announces new olanzapine post-hoc data
17d ago
TEVA
Safe Pro Group (NASDAQ: SPAI) Draws WhaleWatchAlerts Attention Following Phillip Frost’s $4M Share Purchase
PremiumTipRanks Newswire
Safe Pro Group (NASDAQ: SPAI) Draws WhaleWatchAlerts Attention Following Phillip Frost’s $4M Share Purchase
20d ago
OPK
SPAI
Leerink starts Teva with an Outperform with new strategy ‘clearly bearing fruit’
PremiumThe FlyLeerink starts Teva with an Outperform with new strategy ‘clearly bearing fruit’
26d ago
TEVA
Teva initiated with an Outperform at Leerink
Premium
The Fly
Teva initiated with an Outperform at Leerink
27d ago
TEVA
Teva price target raised to $48 from $42 at UBS
Premium
The Fly
Teva price target raised to $48 from $42 at UBS
1M ago
TEVA
Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer
PremiumThe Fly
Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer
1M ago
PFE
PCVX
J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential
PremiumRatings
J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential
1M ago
TEVA
Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data
PremiumRatings
Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data
1M ago
TEVA
Morning Movers: Dell rises, G-III Apparel falls after earnings
PremiumThe Fly
Morning Movers: Dell rises, G-III Apparel falls after earnings
1M ago
CXM
VRT
Teva reports TEV ‘408 study met primary endpoint
PremiumThe FlyTeva reports TEV ‘408 study met primary endpoint
1M ago
TEVA
Teva to lower cost of select medicines for American patients covered by Medicaid
Premium
The Fly
Teva to lower cost of select medicines for American patients covered by Medicaid
1M ago
TEVA
Teva unit bids to acquire neuroscience product from BioXcel Therapeutics
Premium
The Fly
Teva unit bids to acquire neuroscience product from BioXcel Therapeutics
1M ago
BTAI
TEVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >